<![CDATA[Exploring the Rationale for 5-Alpha Reductase Inhibitors in Prostate Cancer Prevention and Active Surveillance]]...
Despite level 1 evidence from the Prostate Cancer Prevention Trial (PCPT) and subsequent studies showing that 5-alpha reductase inhibitors (5-ARIs) can meaningfully reduce the risk of prostate cancer and disease progression in men on active surveillance …